ReviewCurrent hypertension reports2022

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition.

Lakshini Y Herat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.